Cross Reactive Material 197 glycoconjugate vaccines contain privileged conjugation sites
about
A Semi-synthetic Oligosaccharide Conjugate Vaccine Candidate Confers Protection against Streptococcus pneumoniae Serotype 3 Infection.Alternative vaccine administration by powder injection: Needle-free dermal delivery of the glycoconjugate meningococcal group Y vaccineSemisynthetic glycoconjugate vaccine candidate against Streptococcus pneumoniae serotype 5.Bacterially derived synthetic mimetics of mammalian oligomannose prime antibody responses that neutralize HIV infectivity.Meningococcal Vaccines: Current Status and Emerging Strategies.
P2860
Cross Reactive Material 197 glycoconjugate vaccines contain privileged conjugation sites
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Cross Reactive Material 197 glycoconjugate vaccines contain privileged conjugation sites
@ast
Cross Reactive Material 197 glycoconjugate vaccines contain privileged conjugation sites
@en
type
label
Cross Reactive Material 197 glycoconjugate vaccines contain privileged conjugation sites
@ast
Cross Reactive Material 197 glycoconjugate vaccines contain privileged conjugation sites
@en
prefLabel
Cross Reactive Material 197 glycoconjugate vaccines contain privileged conjugation sites
@ast
Cross Reactive Material 197 glycoconjugate vaccines contain privileged conjugation sites
@en
P2093
P2860
P50
P356
P1433
P1476
Cross Reactive Material 197 glycoconjugate vaccines contain privileged conjugation sites
@en
P2093
Anja Resemann
Chakkumkal Anish
Christopher E Martin
Claney Lebev Pereira
Detlev Suckau
Felix Broecker
Peter H Seeberger
Sharavathi Parameswarappa
Uwe Möginger
P2860
P2888
P356
10.1038/SREP20488
P407
P577
2016-02-04T00:00:00Z